New blood cancer treatment works by selectively interfering with cancer cell signalling

University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published today in Nature Communications.

Stressing freedom, vaccine opponents rebranding in virus era

Years before this year's anti-mask and reopening demonstrations, vaccine opponents were working on reinventing their image around a rallying cry of civil liberties and medical freedom.

Ireland locks down for second wave, Germany smashes record daily high

Ireland became the first European country to enter a second national lockdown and Germany's daily cases leapt to a record high as the second wave of coronavirus spread gloom across the continent on Thursday.

Do I need to wear a mask if I'm 6 feet away from others?

Do I need to wear a mask if I'm 6 feet away from others?

Rome and Italy's Lazio region to impose nighttime curfew

Italy's Lazio region, which includes the capital Rome, became the third in the country to institute a curfew on Wednesday, in an effort to contain dramatically rising coronavirus cases.

Germany reports record new virus cases in 24 hours

Germany recorded 11,287 new COVID-19 infections in 24 hours, a sharp jump from the previous day and a record for the country since the outbreak of the pandemic, according to official data Thursday.

Airbnb partners with ex-Apple design star Jony Ive

Airbnb has hired former Apple design chief Jony Ive to work on showcasing the homesharing platform's forthcoming products, it announced Wednesday.

Roche teams up with Atea in US on oral coronavirus treatment

Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised.

Puerto Rico shutters 911 call centers amid coronavirus cases

Both of Puerto Rico's 911 call centers were shut down Wednesday night after several employees tested positive for the coronavirus, officials announced.

Short-video app Quibi shutting down just months after launch

Short-video app Quibi said it is shutting down just six months after its early April launch, having struggled to find customers.

Tesla posts net profit for fifth straight quarter

Tesla charged through a summertime auto industry sales slump in the U.S. to post stronger-than-expected net earnings for the third quarter.

In Dubai, oil-rich UAE sees a new wonder: A coal power plant

A new wonder is rising in the southern desert of Dubai against the backdrop of Persian Gulf beaches, but it's not another skyscraper to grace the futuristic sheikhdom. Instead, it's one of mankind's oldest power sources gaining its own space on the oil-rich Arabian Peninsula—a coal-fired power plant.

Regulators, experts take up thorny vaccine study issues

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.

Trial shows hydroxychloroquine does not prevent COVID-19 in health care workers

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus—health care workers.

Technology shines the light on ovarian cancer treatments

Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments. Even worse—many of those same patients experience toxic and sometimes deadly side effects.

Scientists use gene therapy and a novel light-sensing protein to restore vision in mice

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, provided a Small Business Innovation Research grant to Nanoscope, LLC for development of MCO1. The company is planning a U.S. clinical trial for later this year.

COVID-19 interventions can cut virus infections, severe outcomes, and healthcare needs

Non-pharmaceutical interventions such as voluntary shelter-in-place, quarantines, and other steps taken to control the SARS-CoV-2 virus can reduce the peak number of infections, daily infection rates, cumulative infections, and overall deaths, a new study published in the journal PLOS ONE has found.

Existing heart drugs may help cancer patients respond better to PD(L)1 immunotherapy

Researchers have found that a class of commonly-used heart drugs may also improve patients' responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online.

One mouse at a time: new approach to testing potential drugs for children's cancers

A team of researchers in the US and Australia have developed a way of testing potential drugs for children's cancers so as to take account of the wide genetic diversity of these diseases.

Researchers identify genetic variants linked to toxic side effects from bevacizumab

In the largest study of its kind, researchers have found two common genetic variants that can be used to predict whether or not cancer patients might suffer severe adverse side-effects from the drug bevacizumab.

Analyzing web searches can help experts predict, respond to COVID-19 hot spots

Web-based analytics have demonstrated their value in predicting the spread of infectious disease, and a new study from Mayo Clinic indicates the value of analyzing Google web searches for keywords related to COVID-19.